Back to search

Article

<i>epi</i>Liver a novel tumor specific, high throughput and cost-effective blood test for specific detection of liver cancer (HCC)

2021-02-09

Abstract excerpt

Robust cost effective and high-throughput tests for early detection of cancer in otherwise healthy people could potentially revolutionize public-health and the heavy personal and public burden of the morbidity and mortality from cancer. Several studies have delineated tumor specific DNA methylation profiles that could serve as biomarkers for early detection of Hepatocellular Carcinoma (HCC) as well as other cancer...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1f5fa7d2-b83b-5160-8c42-a3c1bfab8d7f
DOI
10.1101/2021.02.07.21251315
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<i>epi</i>Liver a novel tumor specific, high throughput and cost-effective blood test for specific detection of liver cancer (HCC)DOI 10.1101/2021.02.07.21251315
epiLiver a novel tumor specific, high throughput and cost-effective blood test for specific detection of liver cancer (HCC)Semantic proximity
DNA methylation fingerprint for the diagnosis and monitoring of hepatocellular carcinoma from tissue and liquid biopsiesSemantic proximity
DNA methylation fingerprint of hepatocellular carcinoma from tissue and liquid biopsiesSemantic proximity
Clinical validation of peripheral blood mononuclear cell DNA methylation markers for accurate early detection of hepatocellular carcinoma in Asian patientsSemantic proximity
Hepatocellular Carcinoma Detection by Plasma Methylated DNA: Discovery, Phase I Pilot, and Phase II Clinical ValidationSemantic proximity
Early detection and prognosis evaluation for hepatocellular carcinoma by circulating tumour DNA methylation: A multicentre cohort studySemantic proximity
HepaClear, a blood-based panel combining novel methylated CpG sites and protein markers, for the detection of early-stage hepatocellular carcinomaSemantic proximity
Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinomaSemantic proximity
Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkersSemantic proximity
Plasma cell-free DNA methylomes for hepatocellular carcinoma detection and monitoring after liver resection or transplantationSemantic proximity
Targeted DNA Methylation Analysis by High-Throughput Sequencing in Hepatic Carcinoma Tissue and Adjacent Normal TissuesSemantic proximity
Plasma methylated GNB4 and Riplet as a novel dual-marker panel for the detection of hepatocellular carcinomaSemantic proximity
Select a neighboring publication to make it the new centre.